<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Lower extremity amputation</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Lower extremity amputation</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Lower extremity amputation</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Venkat Kalapatapu, MD</a></dd><dt><span> </span>Section Editors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Joseph L Mills, Sr, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">John F Eidt, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Kathryn A Collins, MD, PhD, FACS</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Nov 29, 2022.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H614727678"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Lower extremity amputation is performed to remove ischemic, infected, necrotic tissue or locally unresectable tumor and, at times, is a life-saving procedure. Peripheral artery disease, alone or in combination with diabetes mellitus, contributes to more than one-half of all amputations; trauma is the second leading cause. The second Trans-Atlantic Inter-Society Consensus Working Group (TASC II) documented an incidence of major amputations due to peripheral artery disease ranging from 12 to 50 per 100,000 individuals per year [<a href="#rid1">1</a>]. The aging population is expected to increase this number by 50 percent in the next 15 years [<a href="#rid2">2</a>].</p><p>Factors that predict the need for lower extremity amputation in patients with extremity ischemia include tissue loss, end-stage kidney disease, poor functional status, and diabetes mellitus. Patients with diabetes have a 10-fold increased risk for lower extremity amputation compared with those who do not have diabetes. Amputees with diabetes are more likely to be severely disabled, experience their initial amputation at a younger age, progress to higher-level amputations, and die at a younger age compared with patients without diabetes [<a href="#rid3">3</a>]. </p><p>The indications and techniques for lower extremity amputation, postoperative care, complications, and outcomes are reviewed here. Techniques for performing lower extremity amputation are discussed elsewhere. (See  <a class="medical medical_review" href="/z/d/html/15186.html" rel="external">"Techniques for lower extremity amputation"</a>.)</p><p class="headingAnchor" id="H1576671070"><span class="h1">TERMINOLOGY</span><span class="headingEndMark"> — </span>Major amputation refers to any amputation performed above the level of the ankle. Foot amputations are those at or below the ankle. </p><p>Amputation performed without an attempt at limb salvage (eg, revascularization, bony repair, soft tissue coverage) is termed primary amputation, whereas amputation following a failed attempt at revascularization is termed secondary amputation. Traumatic amputation refers to limb loss that occurs in the field at the time of injury.</p><p class="headingAnchor" id="H1576671063"><span class="h1">INDICATIONS FOR AMPUTATION</span><span class="headingEndMark"> — </span>The majority of lower extremity amputations are performed for ischemia due to peripheral artery disease [<a href="#rid2">2,4</a>]. Trauma and malignancy account for the remainder of cases [<a href="#rid2">2,4,5</a>]. </p><p>Amputation of the lower extremity<strong> </strong>is indicated for: </p><p class="bulletIndent1"><span class="glyph">●</span>An unsalvageable extremity due to critical limb ischemia in patients with vascular disease. Primary amputation may be the only option for patients without an anatomic option for revascularization or those with medical risk factors that contraindicate revascularization. </p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Peripheral artery disease. (See  <a class="medical medical_review" href="/z/d/html/8215.html" rel="external">"Management of chronic limb-threatening ischemia"</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Acute arterial thrombosis or thromboembolism. (See  <a class="medical medical_review" href="/z/d/html/8213.html" rel="external">"Clinical features and diagnosis of acute lower extremity ischemia"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Trauma resulting in a mangled extremity or failed attempt at limb salvage. (See  <a class="medical medical_review" href="/z/d/html/15150.html" rel="external">"Severe lower extremity injury in the adult patient"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Severe infections with extensive soft tissue or bony destruction, or osteomyelitis. (See  <a class="medical medical_review" href="/z/d/html/7651.html" rel="external">"Clinical manifestations, diagnosis, and management of diabetic infections of the lower extremities"</a> and  <a class="medical medical_review" href="/z/d/html/7662.html" rel="external">"Necrotizing soft tissue infections"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Locally unresectable malignant tumors of the musculoskeletal system [<a href="#rid6">6</a>]. (See  <a class="medical medical_review" href="/z/d/html/7734.html" rel="external">"Overview of multimodality treatment for primary soft tissue sarcoma of the extremities and superficial trunk", section on 'Extremity sarcomas'</a> and  <a class="medical medical_review" href="/z/d/html/109748.html" rel="external">"Surgical resection of primary soft tissue sarcoma of the extremities"</a> and  <a class="medical medical_review" href="/z/d/html/7739.html" rel="external">"Bone sarcomas: Preoperative evaluation, histologic classification, and principles of surgical management", section on 'Indications for amputation'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Frostbite-related gangrene. (See  <a class="medical medical_review" href="/z/d/html/179.html" rel="external">"Frostbite: Emergency care and prevention"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Failed management of acute compartment syndrome. (See  <a class="medical medical_review" href="/z/d/html/358.html" rel="external">"Acute compartment syndrome of the extremities"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Failed management of Charcot's degenerative osteoarthropathy. (See  <a class="medical medical_review" href="/z/d/html/5608.html" rel="external">"Diabetic neuroarthropathy"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Debilitating extremity paralysis, which can be unilateral but is frequently bilateral (eg, paraplegia), from infection or pressure-related complications.</p><p></p><p class="headingAnchor" id="H614727885"><span class="h1">PREOPERATIVE EVALUATION AND PREPARATION</span><span class="headingEndMark"> — </span>Most indications for amputation are elective and should be preceded by preoperative evaluation and preparation of the patient, which includes evaluation of medical risk, nutrition assessment, prosthetic and rehabilitation consultation, and potentially psychological consultation. </p><p>In patients with a grossly infected extremity that cannot be brought under control by aggressive surgical drainage, debridement, and antibiotics (with or without systemic sepsis), or those with an unsalvageable mangled extremity, amputation is an emergency or urgent procedure that should proceed without delay.</p><p class="headingAnchor" id="H614727892"><span class="h2">Medical risk</span><span class="headingEndMark"> — </span>Major amputations (below-knee amputation and higher) carry a significant risk of perioperative morbidity and mortality, particularly in patients with vascular disease. Identification of medical risk factors and appropriate pre- and postoperative medical care may decrease the rate of perioperative complications. In a five-year retrospective study, higher modified frailty index scores were predictors of 30 day readmission after lower extremity amputation [<a href="#rid7">7</a>]. (See  <a class="medical medical_review" href="/z/d/html/6616.html" rel="external">"Evaluation of cardiac risk prior to noncardiac surgery"</a> and  <a class="medical medical_review" href="/z/d/html/6970.html" rel="external">"Strategies to reduce postoperative pulmonary complications in adults"</a> and  <a class="medical medical_review" href="/z/d/html/4814.html" rel="external">"Perioperative medication management"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>Myocardial infarction is the most common cause of death following lower extremity amputation in patients with peripheral artery disease [<a href="#rid8">8,9</a>]. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Pulmonary complications, including atelectasis and pneumonia, complicate 5 percent of major lower extremity amputations [<a href="#rid8">8</a>]. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The incidence of new-onset renal failure after a lower extremity major amputation is 0.6 to 2.6 percent [<a href="#rid8">8,9</a>]. Renal failure is associated with increased operative and long-term mortality.</p><p></p><p class="headingAnchor" id="H614734585"><span class="h2">Psychological evaluation</span><span class="headingEndMark"> — </span>Depression following amputation can result from an adjustment reaction to the surgery and to sudden disability. Risk factors for major depressive disorder following amputation include a young age at time of the amputation, pain, neurotic personality lifestyle, and poor coping skills [<a href="#rid10">10,11</a>]. (See  <a class="medical medical_review" href="/z/d/html/83887.html" rel="external">"Screening for depression in adults"</a>.)</p><p>Posttraumatic stress disorder (PTSD) is common (20 to 22 percent) after amputations for combat or accidental injury. For ischemia-related (nontraumatic) amputations, the incidence of PTSD is less than 5 percent. (See  <a class="medical medical_review" href="/z/d/html/500.html" rel="external">"Posttraumatic stress disorder in adults: Epidemiology, pathophysiology, clinical features, assessment, and diagnosis"</a>.)</p><p class="headingAnchor" id="H2240509085"><span class="h2">Perioperative antibiotics</span><span class="headingEndMark"> — </span>Surgical site infection (SSI) rates following lower extremity amputation remain high. The risk of surgical site infection following amputation depends upon the severity of infection and duration of any prior wounds, as well as the presence of ischemia (see <a class="local">'Infection'</a> below). Antibiotic prophylaxis is recommended for all patients within one hour of the skin incision for lower extremity amputation, regardless of the clinical classification of the surgical wound  (<a class="graphic graphic_table graphicRef51272" href="/z/d/graphic/51272.html" rel="external">table 1</a>) [<a href="#rid12">12,13</a>]. (See  <a class="medical medical_review" href="/z/d/html/4043.html" rel="external">"Antimicrobial prophylaxis for prevention of surgical site infection in adults"</a>.)</p><p>A systematic review identified four randomized trials comparing prophylactic antibiotics with no antibiotics, or placebo, and three trials comparing the efficacy of specific antibiotics [<a href="#rid14">14</a>]. In the largest trial [<a href="#rid15">15</a>], the incidence of wound infection following amputation was significantly lower in 77 patients treated with prophylactic antibiotics compared with 75 treated with placebo (17 versus 38 percent); similar results were reported in the smaller trials [<a href="#rid16">16-18</a>]. </p><p class="headingAnchor" id="H660044826"><span class="h3">Selection</span><span class="headingEndMark"> — </span>For amputation that is not complicated by soft tissue or wound infection or gangrene, intravenous prophylactic antibiotics appropriate for skin flora  (<a class="graphic graphic_table graphicRef87206" href="/z/d/graphic/87206.html" rel="external">table 2</a>) are adequate. </p><p>For any patient undergoing major amputation with clinical evidence of an infected wound with or without concomitant ischemia, broad-spectrum perioperative antibiotics (oral or intravenous) should be administered and are selected in accordance with the local antibiogram and adjusted in response to wound culture and sensitivities. Surveys of the bacteriology of amputation wound infections confirm a wide spectrum of microbial species [<a href="#rid19">19</a>]. Anaerobic coverage should be considered for diabetics. </p><p>In the systematic review, three trials compared the efficacy of specific antibiotics [<a href="#rid14">14</a>]. Among these (methicillin versus cephalothin, <a class="drug drug_general" data-topicid="9749" href="/z/d/drug information/9749.html" rel="external">penicillin G</a> versus <a class="drug drug_general" data-topicid="9230" href="/z/d/drug information/9230.html" rel="external">cefuroxime</a>, benzyl penicillin versus <a class="drug drug_general" data-topicid="8673" href="/z/d/drug information/8673.html" rel="external">amoxicillin</a> + clavulanic acid) [<a href="#rid20">20-22</a>], a significant difference in the incidence of wound infection was found only for benzyl penicillin versus amoxicillin + clavulanic acid (13 versus 77 percent) [<a href="#rid22">22</a>].</p><p class="headingAnchor" id="H1059523280"><span class="h3">Duration</span><span class="headingEndMark"> — </span>Prophylactic perioperative antibiotics are discontinued within 24 hours of the procedure. For patients who are being treated for infected wounds or cellulitis, antibiotics are re-dosed perioperatively and continued postoperatively. </p><p class="bulletIndent1"><span class="glyph">●</span><strong>Contaminated/dirty wounds</strong> – For patients undergoing major amputation associated with wounds classified as "contaminated" or "dirty"  (<a class="graphic graphic_table graphicRef51272" href="/z/d/graphic/51272.html" rel="external">table 1</a>), we re-dose therapeutic antibiotics perioperatively and then continue antibiotics into the postoperative period. Even when no residual infected tissue remains after amputation, the risk for infection likely persists (some feel due to involvement of the lymphatics), so it seems reasonable to continue antibiotics postoperatively. Unfortunately, there are few data to inform the optimal duration. We continue antibiotic therapy for five days starting the day of the amputation, or day of amputation completion in the case of staged amputation. A longer or shorter duration may be appropriate depending on the duration of the prior associated infected wounds as well as the clinical appearance of the tissues at the time of the amputation, the ongoing appearance of the wound after amputation, and the overall clinical course of the patient. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Clean wounds</strong> – For patients undergoing lower extremity amputation without prior associated infection or wounds (clean wound  (<a class="graphic graphic_table graphicRef51272" href="/z/d/graphic/51272.html" rel="external">table 1</a>)), while there is some evidence to support a longer duration of prophylactic antibiotics, we do not feel the potential benefit of reduced SSI outweighs the risks of secondary infection (eg, <em>Clostridioides difficile</em>) or the development of antimicrobial resistance. The surgical site should be monitored daily, and if SSI develops, it should be treated accordingly. (See  <a class="medical medical_review" href="/z/d/html/120681.html" rel="external">"Overview of the evaluation and management of surgical site infection"</a>.)</p><p></p><p class="bulletIndent1">Observational studies comparing perioperative antibiotics (&lt;24 hours) to a longer course following vascular procedures and specifically lower extremity amputation appear to support a longer course of therapy [<a href="#rid23">23-25</a>]. In a study comparing a five-day course of broad-spectrum antibiotics with a three-dose regimen among two cohorts of consecutive amputations, the incidence of amputation wound infection was significantly lower for the five-day group (5 versus 22.5 percent) [<a href="#rid23">23</a>]. However, the incidence <em>of Clostridioides difficile </em>colon infection was higher for those receiving the five-day course of antibiotics (7.5 versus 0 percent). </p><p></p><p class="bulletIndent1">In a later randomized trial, 161 vascular patients undergoing amputation (minor, major) without significant baseline infection were randomly assigned to a 24-hour or five-day course of prophylactic antibiotics [<a href="#rid24">24</a>]. The incidence of SSI was significantly lower for the five-day course (11.8 versus 39.5 percent; based on ASEPSIS scores [<a href="#rid26">26</a>]) as was the incidence of impaired wound healing at the surgical site (22.4 versus 58 percent; based on ASEPSIS scores). In addition, significantly fewer patients receiving the five-day course required revision of their amputation (6.6 versus 21 percent). On univariate analysis, the level of amputation was a significant other factor in determining the risk of SSI and for impaired wound healing. In multivariable logistic regression, with amputation level and other variables controlled, longer antibiotic duration remained significant for reducing SSI. One patient each developed <em>Clostridioides difficile </em>and methicillin-resistant <em>Staphylococcus aureus </em>infection. A limitation of this trial was the lack of blinding of the patient, surgeon, and anesthesiologist; however, the assessors of the primary outcome were blinded.</p><p></p><p class="headingAnchor" id="H1576691576"><span class="h2">Thromboprophylaxis</span><span class="headingEndMark"> — </span>Thromboprophylaxis is administered prior to amputation depending upon individual patient risk, amputation level, and expected level of activity following amputation. Patients undergoing major lower extremity amputation are at high risk for thromboembolism due to the nature of the surgery  (<a class="graphic graphic_table graphicRef83739" href="/z/d/graphic/83739.html" rel="external">table 3</a>) [<a href="#rid27">27-31</a>]. In addition, most patients undergoing amputation at the transmetatarsal level will have weight-bearing restrictions and will be immobilized postoperatively. (See  <a class="medical medical_review" href="/z/d/html/1339.html" rel="external">"Prevention of venous thromboembolic disease in adult nonorthopedic surgical patients"</a>.)</p><p>Indirect evidence from large randomized trials of other orthopedic surgeries (eg, knee replacement) and two small trials and other observational studies in patients undergoing major lower extremity amputation support thromboprophylaxis [<a href="#rid28">28,32-34</a>]. For all major lower extremity amputations, we recommend thromboprophylaxis because it reduces the incidence of venous thromboembolism. In older reviews, deep vein thrombosis is reported in up to 50 percent of patients following major lower extremity amputation without prophylaxis [<a href="#rid29">29,31</a>]. With prophylaxis, venous thromboembolism occurs in 10 to 15 percent of patients [<a href="#rid27">27,28,30,35</a>]. In a randomized trial that compared low-molecular-weight heparin and <a class="drug drug_general" data-topicid="8518" href="/z/d/drug information/8518.html" rel="external">unfractionated heparin</a> for prophylaxis, the incidence of deep vein thrombosis was 10 percent with no differences between the groups [<a href="#rid27">27</a>].</p><p class="headingAnchor" id="H2800105286"><span class="h1">LEVEL AND AMPUTATION TYPES</span></p><p class="headingAnchor" id="H3104748079"><span class="h2">Amputation level</span><span class="headingEndMark"> — </span>The level of the amputation is dictated by the extent of the disease, healing potential of the stump, and rehabilitation potential of the patient. Although preservation of limb length is desirable, removal of all nonviable and infected tissue is a higher priority. </p><p>The surgeon must be satisfied that sufficient arterial perfusion is present at the proposed amputation level to sustain healing. The level of amputation is determined by a combination of a thorough physical examination supplemented by objective testing in patients with clinical symptoms and signs of lower extremity ischemia. In one study, 68.4 percent of patients underwent objective arterial testing prior to nontraumatic amputation [<a href="#rid36">36</a>]. Older age, male sex, being a Black person, renal disease, diabetes mellitus, known peripheral artery disease, evaluation by a vascular specialist, and living in the East North Central region were associated with greater rates of preoperative arterial testing. (See  <a class="medical medical_review" href="/z/d/html/8201.html" rel="external">"Noninvasive diagnosis of upper and lower extremity arterial disease"</a>.)</p><p>Determination of amputation level by means of physical examination and clinical judgment alone results in healing in 80 percent of below-knee amputations (BKAs) and 90 percent of above-knee amputations (AKAs) [<a href="#rid37">37</a>]. The presence of a palpable pulse proximal to the level of amputation is associated with a healing rate of nearly 100 percent. The absence of a palpable pulse does not necessarily imply wound healing failure of the amputation stump; however, the rate of revision following major amputation may be higher. </p><p>Various objective tests can supplement the clinical examination to assist the choice of amputation level. These include ankle pressures, toe pressures, transcutaneous oxygen measurements, and skin perfusion pressure. The sensitivity of these studies for predicting wound healing is low, ranging from 60 to 74 percent, and thus, these tests should not be used to replace clinical judgment [<a href="#rid38">38,39</a>]. </p><p>It is also important that structural integrity of the bony architecture of the residual limb is adequate. As an example, for some patients with diabetes and Charcot's degenerative osteoarthropathy of the foot, ongoing instability of the metatarsals may favor transtibial amputation over complex foot salvage procedures.</p><p class="headingAnchor" id="H1434397871"><span class="h2">Standard and osseointegrated amputations</span><span class="headingEndMark"> — </span>Major standard amputations include hip disarticulation, AKA, knee disarticulation, and BKA. These amputations use a standard socket prosthesis. A variety of foot amputations are also available that can salvage the patient's ability to ambulate with orthotic modifications, including mid- and hindfoot amputation (eg, Lisfranc, Chopart, Syme), transmetatarsal amputation, and digit amputations. Major amputation and foot amputation techniques are discussed in detail elsewhere. (See  <a class="medical medical_review" href="/z/d/html/15186.html" rel="external">"Techniques for lower extremity amputation"</a>.)</p><p>If the stump is short, or for patients who cannot tolerate or use a standard socket prosthesis, an alternative option to a standard amputation and socket prosthesis is the technique of osseointegration, which fundamentally involves integration of the prosthesis into the appendicular skeleton. This technique has been used in transfemoral as well as transtibial amputations in the lower extremity [<a href="#rid40">40-42</a>]. Most studies have been done in patients without significant peripheral artery disease or associated diabetes. The anchoring system is implanted directly into the bone using a two-stage procedure. The Osseoanchored Prostheses for the Rehabilitation of Amputees (OPRA) Implant System has been approved for use in the United States [<a href="#rid43">43</a>]. Other systems include the Integral Leg Prosthesis (ILP) [<a href="#rid44">44</a>] and the Osseointegrated Prosthetic Limb (OPL) [<a href="#rid45">45</a>]. </p><p class="headingAnchor" id="H614729004"><span class="h1">POSTOPERATIVE CARE</span><span class="headingEndMark"> — </span>Postoperative care of amputation patients requires multidisciplinary cooperation. Anesthesiology pain services, rehabilitation medicine, physical therapy, and psychiatry services each contribute to the patient's postoperative recovery. </p><p>More than one third of perioperative (&lt;30 days) deaths after major amputation occur after discharge from acute care [<a href="#rid46">46</a>]. Patients who have an increased risk for mortality may benefit from continued hospitalization or, if discharged, close postoperative follow-up. (See <a class="local">'Perioperative mortality'</a> below.)</p><p class="headingAnchor" id="H1576671369"><span class="h2">Wound care</span><span class="headingEndMark"> — </span>Following amputation, the incision should be examined daily for signs of infection (erythema, excess warmth, wound drainage), particularly in patients with unexplained fever or excessive stump pain. Drains placed into the wound at the time of the surgery are maintained until volume in the drain reservoir is minimal; thereafter, the drain can be removed. </p><p>Open wounds (eg, open amputation, soft tissue defect, stump breakdown) are managed with moist <a class="drug drug_general" data-topicid="9929" href="/z/d/drug information/9929.html" rel="external">saline</a> dressings. Once the wounds have stabilized and no necrotic debris is apparent, negative pressure wound therapy may be useful [<a href="#rid47">47</a>]. (See  <a class="medical medical_review" href="/z/d/html/15912.html" rel="external">"Basic principles of wound management", section on 'Wound dressings'</a> and  <a class="medical medical_review" href="/z/d/html/2881.html" rel="external">"Negative pressure wound therapy"</a>.)</p><p>Preventing wound contamination from urine and stool can be challenging following hip disarticulation and above-knee amputation. A urinary drainage catheter is typically placed at the time of major amputation and can be maintained for a few days postoperatively if a problem is anticipated but should be removed as soon as possible. (See  <a class="medical medical_review" href="/z/d/html/8090.html" rel="external">"Placement and management of urinary bladder catheters in adults", section on 'Catheter removal'</a>.)</p><p>The skin overlying the sacrum and other bony protuberances should be inspected frequently for signs of decubitus ulcer. (See  <a class="medical medical_review" href="/z/d/html/2885.html" rel="external">"Prevention of pressure-induced skin and soft tissue injury"</a>.)</p><p class="headingAnchor" id="H614729011"><span class="h2">Stump pain</span><span class="headingEndMark"> — </span>Acute stump pain following amputation gradually subsides over a one- to three-week period of time. Optimal management of preoperative and postoperative pain in patients undergoing amputation may be important for reducing the risk of phantom limb pain [<a href="#rid48">48</a>]. Multimodality pain management is the cornerstone of successful amputation rehabilitation and consists of a combination of epidural, intravenous, and oral analgesics [<a href="#rid48">48,49</a>]. Depression may complicate the treatment of pain in many amputees [<a href="#rid49">49</a>]. A detailed discussion of the management of postoperative pain is found elsewhere. (See  <a class="medical medical_review" href="/z/d/html/130312.html" rel="external">"Approach to the management of acute pain in adults"</a>.)</p><p>Chronic pain, to some degree, is reported by up to 95 percent of amputees [<a href="#rid49">49</a>]. Persistent pain may be a sign of stump ischemia, neuroma formation, infection, or a manifestation of phantom limb syndrome. </p><p class="bulletIndent1"><span class="glyph">●</span>Ischemic stump pain may be difficult to detect by physical examination alone but can be confirmed by a transcutaneous oxygen tension less than 20 mmHg at the level of the stump. (See  <a class="medical medical_review" href="/z/d/html/8201.html" rel="external">"Noninvasive diagnosis of upper and lower extremity arterial disease", section on 'Transcutaneous oxygen measurements'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Neuroma can develop at the site of transection of virtually any peripheral nerve, and is relatively common [<a href="#rid50">50,51</a>]. The pain is usually well localized to the site of injury and can be transiently blocked with anesthetic injection. Heterogeneity on T2 weighted magnetic resonance imaging may indicate that a neuroma is likely to be symptomatic [<a href="#rid52">52</a>]. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Pressure points that develop over bone spurs or pathologic bone formation can also be a source of localized pain and can be identified by obtaining a plain radiograph of the stump.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Infection (osteomyelitis, residual graft infection) can also be a source of chronic postoperative pain.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Phantom limb syndrome is a diagnosis of exclusion after the other causes of stump pain listed above have been eliminated. (See <a class="local">'Phantom limb pain'</a> below.)</p><p></p><p class="headingAnchor" id="H614729018"><span class="h2">Weight bearing and ambulation</span><span class="headingEndMark"> — </span>The duration of non-weight-bearing in the residual limb depends upon the level of the amputation and whether there are any anticipated wound healing issues. Patients who are nonambulatory should receive prophylaxis for deep vein thrombosis until their activity restriction is lifted. (See <a class="local">'Thromboprophylaxis'</a> above.)</p><p>For amputations that are related to lower extremity ischemia, no weight bearing is allowed until the wound is thoroughly healed, which can take up to six weeks for major amputations. Younger patients undergoing major amputation for other indications may be candidates for immediate postoperative prostheses and ambulation. (See <a class="local">'Immediate postoperative prosthesis'</a> below.)</p><p>An elastic stump "shrinker" is applied after adequate wound healing of major amputation stumps to reduce edema and facilitate molding of the stump for a future prosthetic. Ambulation on a prosthetic is undertaken gradually under the direction of a multidisciplinary rehabilitation team. </p><p>For toe amputation, a rocker-bottom shoe with a metatarsal bar can be used in selected patients and allows ambulation while eliminating pressure to the toe wound. Older patients and patients with diabetes often find it difficult to maintain their balance using these shoes. </p><p>Following transmetatarsal and proximal foot amputation, weight bearing is allowed after six weeks provided the wounds are adequately healed. With an appropriate orthotic, the patient can be expected to ambulate with an almost imperceptible alteration in their gait once healing is complete.</p><p class="bulletIndent1"><span class="glyph">●</span>Transmetatarsal amputation: Shoe-filler and normal shoe</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Lisfranc amputation: Shoe-filler with an ankle-high lace-up shoe</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Chopart: Custom-fitted ankle foot orthosis with a filler, and ankle-high lace-up shoe</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Syme: Syme amputation prosthesis</p><p></p><p class="headingAnchor" id="H614729025"><span class="h3">Immediate postoperative prosthesis</span><span class="headingEndMark"> — </span>Immediate postoperative prosthesis (IPOP) was developed to reduce the time to ambulation with a prosthetic [<a href="#rid53">53</a>]. Advocates of IPOP report that more patients are able to achieve earlier ambulation on a prosthetic compared with conventional rehabilitation [<a href="#rid53">53,54</a>]. Disadvantages of IPOP are that the rigid prosthetic limits access to the wound for examination, and that the skilled multidisciplinary team needed for its implementation is not universally available [<a href="#rid55">55,56</a>]. IPOP may play a role in elective amputation in patients who have no vascular issues, but it is generally not useful for patients with peripheral artery disease due to the frequency of stump complications. </p><p class="headingAnchor" id="H1349290578"><span class="h3">Alternative prostheses</span></p><p class="bulletIndent1"><span class="glyph">●</span>An alternative to a standard socket prosthesis after lower extremity amputation is an osseointegrated prosthesis. (See <a class="local">'Standard and osseointegrated amputations'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Another option is the use of a powered exoskeleton [<a href="#rid57">57-60</a>]. In an evaluation of six individuals with an above-knee amputation, use of an autonomous powered hip exoskeleton significantly improved metabolic walking economy by 16 percent [<a href="#rid58">58</a>].</p><p></p><p class="headingAnchor" id="H614729032"><span class="h1">COMPLICATIONS</span><span class="headingEndMark"> — </span>Complications following lower extremity amputation are common and include medical complications related to preexisting cardiac and pulmonary conditions and local complications related to the surgery, which is discussed below. </p><p>Cardiopulmonary complications are a common cause of morbidity and mortality, which is not surprising given the incidence of cardiovascular disease, diabetes, and smoking in patients with peripheral artery disease. A retrospective review of 959 major amputations reported a cardiac complication rate of 10.2 percent. Complications included arrhythmias (2.6 percent), heart failure (4.2 percent), and myocardial infarction (3.4 percent) [<a href="#rid8">8</a>]. Another study of 154 patients undergoing 172 major amputations found that 63 percent of perioperative deaths were due to cardiac disease [<a href="#rid9">9</a>]. Identification of risk factors for cardiovascular and pulmonary disease and institution of preventive strategies are important to limit these complications and reduce mortality associated with them. (See <a class="local">'Medical risk'</a> above.)</p><p>For below-knee amputation, a review of the National Surgical Quality Improvement Program (NSQIP) database identified a 34 percent incidence of perioperative (30 day) complications in 2911 patients. The most common major complications were return to the operating room in 15.6 percent of patients, wound infection in 9.3 percent, and postoperative sepsis in 9.3 percent [<a href="#rid61">61</a>]. A history of sepsis, alcohol use, glucocorticoid use, cardiac disease, renal insufficiency, and contaminated/infected wounds independently predicted the development of one or more complications. </p><p>Another analysis of the NSQIP database evaluated wound occurrences defined as superficial infection, deep infection, and/or wound disruption following below-knee (2309 patients) or above-knee amputation (1941 patients) [<a href="#rid62">62</a>]. Wound occurrences were present in 10.4 percent of below-knee amputations and 7.2 percent of above-knee amputations. Independent predictors of wound occurrence in patients with below-knee amputation included age and elevated international normalized ratio (INR; odds ratio [OR] 1.5 for each integer increase in INR, 95% CI 1.1-1.93). For above-knee amputation, predictors of wound occurrence included a history of smoking within the year (OR 1.9, 95% CI 1.31-2.74) and increasing body mass index (OR 1.3 for every 10 kg/m<sup>2</sup> increase, 95% CI 1.01-1.05). In a separate review, risk factors associated with unplanned operation after above-knee amputation included prior revascularization, multiple indications for amputation, wound breakdown, and hematoma [<a href="#rid63">63</a>].</p><p class="headingAnchor" id="H1046373731"><span class="h2">Deep vein thrombosis</span><span class="headingEndMark"> — </span>Deep vein thrombosis (DVT) has been reported in up to 50 percent of patients following major lower extremity amputation without prophylaxis [<a href="#rid31">31</a>]. The incidence of DVT is higher for above-knee amputation compared with below-knee amputation (37.5 versus 21.2 percent, respectively) [<a href="#rid64">64</a>]. This difference may contribute to the increased incidence of sudden death due to thromboembolism in patients with above-knee amputation. Thus, it is important to provide thromboprophylaxis. (See <a class="local">'Thromboprophylaxis'</a> above and <a class="local">'Perioperative mortality'</a> below.)</p><p class="headingAnchor" id="H614729039"><span class="h2">Stump hematoma</span><span class="headingEndMark"> — </span>Postoperative bleeding that requires reoperation occurs in 3 to 9 percent of major lower extremity amputations, and stump hematoma may lead to stump wound breakdown [<a href="#rid9">9,65</a>]. Patients on antithrombotic therapy, including DVT prophylaxis, are at a higher risk for stump hematoma. Patients with stump hematoma causing pain and stump swelling with or without drainage should have the wound opened partially, the hematoma evacuated, and the wound washed out and packed with a moist <a class="drug drug_general" data-topicid="9929" href="/z/d/drug information/9929.html" rel="external">saline</a> dressing.</p><p class="headingAnchor" id="H614729046"><span class="h2">Infection</span><span class="headingEndMark"> — </span>Wound infection following major lower extremity amputation occurs in 13 to 40 percent of patients [<a href="#rid19">19,23,66</a>]. Patients with diabetes, preoperative wound infection, malnutrition, malignancy, advanced age, wound hematoma, and prior prosthetic bypass grafts have an increased risk for stump wound infection. In patients with prior lower extremity bypass graft, stump infection rates are reduced by complete removal of synthetic graft material [<a href="#rid67">67</a>].</p><p>Superficial wound infections are treated by removing the skin sutures and initiating broad-spectrum antibiotics, which are adapted to reflect the results of wound culture and sensitivities. Deeper wound infection requires operative management with removal of skin and fascial sutures, drainage and washout of the wound, and debridement of any nonviable tissue  (<a class="graphic graphic_picture graphicRef101204" href="/z/d/graphic/101204.html" rel="external">picture 1</a>).</p><p class="headingAnchor" id="H1576717368"><span class="h2">Need for re-amputation</span><span class="headingEndMark"> — </span>The rate of revision following major amputation remains high despite the availability of a variety of methods to select amputation level. (See <a class="local">'Amputation level'</a> above.)</p><p>The need for re-amputation at a more proximal level is inversely related to the level of the index amputation. Following toe amputation  (<a class="graphic graphic_picture graphicRef101200" href="/z/d/graphic/101200.html" rel="external">picture 2</a>), 25 to 50 percent of patients eventually undergo additional amputations compared with 10 to 20 percent of patients undergoing below-knee amputation (BKA) [<a href="#rid3">3,8,9,68-73</a>]. Patients with diabetes are almost twice as likely to require re-amputation as patients without diabetes [<a href="#rid68">68,72</a>]. In one study, the one-, three-, and five-year ipsilateral re-amputation rates for patients with diabetes were 23, 40, and 52 percent for toe amputations; 29, 41, and 50 percent for ray amputations; 19, 33, and 43 percent for midfoot amputations; and 5, 12, and 13 percent for major amputations [<a href="#rid68">68</a>]. In a study analyzing factors that predict long-term resource utilization and survival after major amputation, complicated diabetes, renal failure, and index below-knee amputation were each associated with an increased need for additional amputation-related procedures [<a href="#rid74">74</a>]. In a review of 8878 amputations at a variety of levels, independent risk factors associated with early amputation failure included emergency operation, transmetatarsal amputation, sepsis, septic shock, end-stage kidney disease, systemic inflammatory response syndrome, intraoperative surgical trainee participation, body mass index ≥30, and ongoing tobacco use [<a href="#rid75">75,76</a>]. </p><p>Complete healing of a major amputation may be quite protracted. One retrospective review found that at 100 days postoperatively, 45 percent of transtibial and 24 percent of transfemoral amputations were not yet completely healed [<a href="#rid9">9</a>]. Approximately 20 to 30 percent of wounds fail to heal primarily, and of these, only about 50 percent are salvaged at the same level [<a href="#rid3">3,8,9,69</a>]. Re-amputation at the transfemoral level is needed in 10 to 20 percent of patients who initially underwent below-knee amputation [<a href="#rid3">3,8,9,69-71,73</a>]. Between 9 and 17 percent of patients undergoing transtibial amputation will require <strong>contralateral</strong> major amputation within 12 months [<a href="#rid3">3,8,69,70,73,77</a>].</p><p>Following foot or ankle amputation, approximately 35 percent of patients progress to a higher-level amputation within one year [<a href="#rid3">3,68,78-82</a>]. </p><p>For toe amputations, wound failure occurs in approximately 25 percent [<a href="#rid68">68</a>]. Of patients who require revision of toe amputation, approximately 40 percent are performed at the transtibial level [<a href="#rid3">3</a>]. </p><p class="headingAnchor" id="H614734724"><span class="h2">Phantom limb pain</span><span class="headingEndMark"> — </span>True phantom limb pain is a complex, poorly understood pain syndrome that is described as burning, aching, or electric-type pain in the amputated limb [<a href="#rid49">49</a>]. There is no clear consensus on the mechanisms of this disorder and no standard treatment [<a href="#rid83">83</a>]. The diagnosis of phantom pain should only be made after other causes of stump pain have been eliminated, including ischemia, infection, neuroma, and pressure-related wounds. (See <a class="local">'Stump pain'</a> above.)</p><p>The incidence of phantom pain widely varies in the literature, ranging from 50 to 85 percent depending upon the diagnostic criteria used to define the syndrome [<a href="#rid84">84,85</a>]. Inadequate control of preoperative and postoperative pain may increase the risk of chronic amputation pain [<a href="#rid86">86</a>]. The use of preemptive epidural anesthesia may reduce the incidence and severity of phantom pain [<a href="#rid48">48,87</a>]. </p><p>Systematic reviews have identified low-to-moderate-quality trials using a variety of pharmacologic agents (eg, <a class="drug drug_general" data-topicid="8483" href="/z/d/drug information/8483.html" rel="external">gabapentin</a>, <a class="drug drug_general" data-topicid="10131" href="/z/d/drug information/10131.html" rel="external">memantine</a>, <a class="drug drug_general" data-topicid="8588" href="/z/d/drug information/8588.html" rel="external">ketamine</a>, <a class="drug drug_general" data-topicid="8605" href="/z/d/drug information/8605.html" rel="external">amitriptyline</a>, <a class="drug drug_general" data-topicid="9648" href="/z/d/drug information/9648.html" rel="external">mexiletine</a>, or <a class="drug drug_general" data-topicid="9558" href="/z/d/drug information/9558.html" rel="external">lidocaine</a>) or other treatments (mirror therapy, virtual reality, peripheral nerve stimulation) to manage phantom limb pain after upper limb, lower limb, and digit amputations [<a href="#rid88">88-94</a>]. Most trials were small, and it is unclear whether the reported outcomes constituted a meaningful reduction in phantom limb pain. A novel approach incorporating sensory feedback from a specialized prosthetic may help reduce the perception of pain [<a href="#rid95">95,96</a>]. Another promising approach is target muscle reinnervation (TMR) [<a href="#rid97">97</a>]. The principles of TMR are similar for the lower and upper extremity. (See  <a class="medical medical_review" href="/z/d/html/15224.html" rel="external">"Upper extremity amputation", section on 'Target muscle reinnervation'</a>.)</p><p>In the absence of specific data to suggest better efficacy for treating phantom limb pain over other types of pain, we approach therapy in a manner similar to treatment of other conditions leading to chronic neuropathic pain, which is discussed in more detail separately. (See  <a class="medical medical_review" href="/z/d/html/126633.html" rel="external">"Pharmacologic management of chronic non-cancer pain in adults", section on 'Pharmacologic therapy for neuropathic pain, or nociplastic or centralized pain'</a>.) </p><p class="headingAnchor" id="H1576717148"><span class="h2">Flexion contracture</span><span class="headingEndMark"> — </span>Flexion contracture at the hip or knee joint (15° limitation) occurs in 3 to 5 percent of major lower extremity amputations. Although up to 15° hip contracture can be accommodated with prosthetic alignment, a more than 25° contracture will cause compensatory lumbar lordosis, leading to low back pain. Contractures are more likely to develop in older patients, particularly those with dementia or prior ipsilateral stroke. Failure to provide adequate postoperative analgesia may also result in flexion contracture. Once a significant contracture develops, it may not be possible to correct it with physical therapy or surgery [<a href="#rid98">98</a>]. </p><p>Hip flexion contracture can be retarded with prone positioning; however, patients may not tolerate this position. </p><p>Because a fixed flexion contracture can limit prosthetic ambulation, preventive measures are undertaken immediately following amputation. A rigid, removable dressing is applied intraoperatively and maintained postoperatively to straighten the knee, and an aggressive postoperative knee exercise program is undertaken as soon as allowable, taking into account the patient pain threshold and healing of the wound. (See  <a class="medical medical_review" href="/z/d/html/15186.html" rel="external">"Techniques for lower extremity amputation", section on 'Dressings and drains'</a>.)</p><p class="headingAnchor" id="H614734094"><span class="h1">FUNCTIONAL OUTCOMES</span><span class="headingEndMark"> — </span>A good functional outcome can be achieved in most patients but may be largely dependent upon the patient's preoperative functional status, other comorbidities, and the level of the amputation. </p><p>Near-normal ambulation with conventional footwear is likely following toe, ray, and transmetatarsal amputation. Shoe fillers and simple orthotics are usually sufficient to allow ambulation for the majority of patients [<a href="#rid78">78-80,99-101</a>]. </p><p>Following amputation of the proximal foot, patients can expect to ambulate with almost imperceptible gait alteration with the use of appropriate orthotics. However, because Lisfranc and Chopart amputations cause dramatic alterations in normal foot biomechanics, the durability of these amputations may be limited, particularly in patients with diabetes.</p><p>Following major amputation for injury or malignancy in otherwise healthy patients, ambulation with a prosthetic can generally be expected. The outcomes for patients with severe extremity trauma depend upon the integrity of each of the functional components of the extremity (nerves, vessels, bones, soft tissues). These outcomes are discussed elsewhere. (See  <a class="medical medical_review" href="/z/d/html/16732.html" rel="external">"Surgical management of severe lower extremity injury", section on 'Amputation and functional outcomes'</a>.)</p><p>Successful ambulation with a prosthetic is less likely in patients who have undergone major amputation for peripheral artery disease [<a href="#rid9">9,102-104</a>]. The outcomes of rehabilitation vary widely depending on the definition of success. Only approximately 25 percent of major lower extremity amputees due to peripheral artery disease ambulate with a prosthetic outside the home. Patients are not able to use a prosthetic for a variety of reasons, including mental illness, poor cardiopulmonary reserve, inadequate balance, and stump-related issues. </p><p>Significant preoperative patient factors that are independently associated with an increased risk of not being able to use a prosthetic include the following [<a href="#rid104">104</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Nonambulatory before amputation (odds ratio [OR] 9.5, 95% CI 4.5-20.2)</p><p class="bulletIndent1"><span class="glyph">●</span>Above-knee amputation (OR 4.4, 95% CI 2.6-7.4)</p><p class="bulletIndent1"><span class="glyph">●</span>Age &gt;70 years (OR 3.0, 95% CI 1.5-5.8)</p><p class="bulletIndent1"><span class="glyph">●</span>Homebound but ambulatory status (OR 3.0, 95% CI 1.6-6.2)</p><p class="bulletIndent1"><span class="glyph">●</span>Dementia (OR 2.4, 95% CI 1.3-4.1)</p><p class="bulletIndent1"><span class="glyph">●</span>End-stage kidney disease (OR 2.3, 95% CI 1.5-3.7)</p><p class="bulletIndent1"><span class="glyph">●</span>Coronary artery disease (OR 2.0, 95% CI, 1.3-3.2) </p><p></p><p>The energy required for ambulation with an above-knee amputation (AKA) is approximately 50 percent higher than after below-knee amputation (BKA). Fewer than 10 percent of elderly vascular amputees can be expected to ambulate effectively after AKA [<a href="#rid9">9,69,102,104,105</a>]. </p><p>Despite the fact that few patients with peripheral artery disease ambulate with a prosthetic outside the home, most amputees maintain their preoperative living status. Thus, most patients living independently prior to major amputation remain independent postoperatively. Highly motivated patients, as evidenced by commitment to a strict rehabilitation program including smoking cessation and weight loss, are more likely to achieve long-term success [<a href="#rid106">106</a>]. Patients with financial resources that allow participation in a well-organized rehabilitation program are also more likely to be successful. The following preoperative factors were found to be significantly associated with an increased risk of being unable to maintain independent living status following amputation [<a href="#rid104">104</a>]: </p><p class="bulletIndent1"><span class="glyph">●</span>Age ≥70 years (hazard ratio [HR] 4.0, 95% CI 1.7-9.5)</p><p class="bulletIndent1"><span class="glyph">●</span>Age 60 to 69 (HR 2.7, 95% CI 1.1-6.5)</p><p class="bulletIndent1"><span class="glyph">●</span>Above-knee amputation (HR 1.8, 95% CI 1.2-2.8)</p><p class="bulletIndent1"><span class="glyph">●</span>Homebound status (HR 1.6, 95% CI 1.1-2.6)</p><p class="bulletIndent1"><span class="glyph">●</span>Dementia (HR 1.6, 95% CI 1.1-2.4) </p><p></p><p>A later study that evaluated the effect of rehabilitation setting on functional outcomes of 297 patients found that those who received postoperative care at an acute inpatient rehabilitation facility had better functional outcome at six months compared with patients who were treated at a skilled nursing facility or at home [<a href="#rid107">107</a>]. </p><p class="headingAnchor" id="H614729088"><span class="h1">PERIOPERATIVE MORTALITY</span><span class="headingEndMark"> — </span>Mortality in the immediate postoperative period is related to the indication for the amputation, associated medical comorbidities (eg, peripheral artery disease, diabetes), and complicating infection [<a href="#rid108">108</a>]. The most common causes of death following amputation for peripheral artery disease are cardiac complications, sepsis, and pneumonia [<a href="#rid8">8,9</a>]. Another important cause of mortality following amputation is thromboembolism from deep vein thrombosis. Mortality related directly to the operation, such as due to blood loss or postoperative infection, is much less common. (See <a class="local">'Deep vein thrombosis'</a> above.) </p><p>Mortality rates as high as 40 percent have been reported following major amputation in the past [<a href="#rid109">109-111</a>], but in contemporary series, 30 day mortality rates for major amputation range from 3 to 18 percent [<a href="#rid3">3,8,9,69-71,73,112-118</a>]. A higher level of amputation correlates with increased mortality and may reflect the severity of systemic cardiovascular disease, or differences in the incidence of thromboembolism rather than the magnitude of the procedure [<a href="#rid112">112</a>]. Mortality for above-knee amputation (AKA) ranges from 11 to 18 percent compared with 4 to 9 percent for below-knee amputation (BKA) [<a href="#rid3">3,8,9,61,62,69-71,73,112-116,119</a>]. In a study of 9368 patients from the American College of Surgeons (ACS) National Surgical Quality Improvement Program (NSQIP) database, perioperative (30 day) mortality was 12.8 percent for AKA and 6.5 percent for BKA [<a href="#rid118">118</a>]. Mortality following amputation of the foot (total or partial) is 2 to 7 percent [<a href="#rid78">78-81,99,120,121</a>]. </p><p>Factors that increase the risk for mortality following major amputation include age over 80, dependent functional status, dialysis, glucocorticoid use, preoperative sepsis, delirium, thrombocytopenia, coagulopathy, and renal insufficiency [<a href="#rid61">61,62,117-119,122,123</a>]. Additional factors for mortality include heart failure, dyspnea, low body mass index for AKA, and chronic obstructive pulmonary disease and previous cardiac surgery for BKA [<a href="#rid118">118</a>]. In a separate study, renal failure increased the incidence of death (62 percent) in patients undergoing BKA more than threefold over the second most important independent risk factor, which was cardiac disease [<a href="#rid61">61</a>]. A study found that preoperative septic shock and thrombocytopenia were independent risk factors for perioperative (30 day) mortality after AKA, while burn etiology, leukocytosis, and guillotine amputation contributed to prolonged length of stay [<a href="#rid124">124</a>].</p><p>Guillotine amputation, which is often used to manage sepsis, is also associated with increased mortality. In one study, the 30 day mortality rate was 14 percent for guillotine amputation compared with 8 percent for elective amputation [<a href="#rid8">8</a>]. </p><p>Patients presenting with extremity injury who require amputation have lower mortality rates compared with patients with peripheral artery disease and are more likely to die from associated injuries (eg, traumatic brain injury, abdominal injury). (See  <a class="medical medical_review" href="/z/d/html/16732.html" rel="external">"Surgical management of severe lower extremity injury", section on 'Mortality'</a>.)</p><p class="headingAnchor" id="H614729104"><span class="h1">LONG-TERM SURVIVAL</span><span class="headingEndMark"> — </span>Long-term survival following major lower extremity amputation in patients with peripheral artery disease has improved but remains significantly lower than age-matched controls [<a href="#rid65">65,112,114,125-127</a>]. In one study, the overall survival after above-knee amputation was 78 percent at one year and 55 percent at three years [<a href="#rid9">9</a>]. </p><p>Long-term survival is worse for patients with more proximal amputation, diabetes, and renal dysfunction but does not appear to be related to previous revascularization procedures, gender, or a history<sup> </sup>of hypertension [<a href="#rid5">5,128,129</a>]. Whether there are any ethnic or racial differences remains unsettled [<a href="#rid114">114,130,131</a>]. </p><p class="bulletIndent1"><span class="glyph">●</span>One-year survival is 50 to 60 percent following above-knee amputation and 65 to 80 percent for below-knee amputation  (<a class="graphic graphic_figure graphicRef79554" href="/z/d/graphic/79554.html" rel="external">figure 1</a>) [<a href="#rid3">3,8,71,112,113,116,126</a>]. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Long-term survival for patients with diabetes is generally worse compared with patients without diabetes. In a review of 788 patients, five-year survival for patients with diabetes was 31 percent compared with 51 percent for patients without diabetes [<a href="#rid8">8</a>]. In another study, the median time to death was 27 months in patients with diabetes compared with 47 months following amputation [<a href="#rid72">72</a>]. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In a review of 788 patients who underwent major amputation, one-year survival was 52 percent for dialysis-dependent patients compared with 75 percent in patients with normal renal function [<a href="#rid8">8</a>]. For patients who were not dialysis dependent but had a preoperative<sup> </sup>serum<sup> </sup>creatinine &gt;2 mg/dL, one-year survival was not significantly different (56 versus 52 percent) compared with dialysis-dependent<sup> </sup>patients. </p><p></p><p class="headingAnchor" id="H3950638935"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/z/d/html/120396.html" rel="external">"Society guideline links: Severe blunt or penetrating extremity trauma"</a> and  <a class="medical medical_society_guidelines" href="/z/d/html/119797.html" rel="external">"Society guideline links: Soft tissue sarcoma"</a>.)</p><p class="headingAnchor" id="H614730646"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Lower extremity amputation</strong> – Lower extremity amputation is indicated for a variety of reasons to remove ischemic, infected, or necrotic tissue or locally unresectable tumor and, at times, may be lifesaving. Peripheral artery disease and diabetes are the leading causes of nontraumatic lower extremity amputation in the United States. (See <a class="local">'Introduction'</a> above and <a class="local">'Indications for amputation'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Preoperative preparation</strong> – Prior to amputation, medical, prosthetic, rehabilitation, and, potentially, psychological consultation should be obtained. (See <a class="local">'Preoperative evaluation and preparation'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>For all patients undergoing lower extremity amputation who are not already receiving antibiotics for associated soft tissue infection, we recommend perioperative prophylactic antibiotics (<a class="grade" href="https:///uptodate/show/grade_1" rel="external">Grade 1A</a>). Prophylactic antibiotics significantly reduce the incidence of amputation wound infection. The choice of antibiotic therapy and duration depend upon the clinical situation. (See <a class="local">'Perioperative antibiotics'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>We recommend thromboprophylaxis for all patients undergoing major lower extremity amputation (transtibial and above) (<a class="grade" href="https:///uptodate/show/grade_2" rel="external">Grade 1B</a>). Patients undergoing major lower extremity amputation are at high risk for thromboembolism. Without prophylaxis, deep vein thrombosis (DVT) has been reported in up to 50 percent of patients following major lower extremity amputation. Pharmacologic prophylaxis reduces the incidence of DVT to approximately 10 percent. (See <a class="local">'Thromboprophylaxis'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Amputation level</strong> – The level of the amputation is dictated by the extent of the disease, healing potential of the stump, and rehabilitation potential of the patient. The presence of a palpable pulse proximal to the level of amputation is associated with a healing rate of nearly 100 percent, but the absence of a palpable pulse does not imply that the incision will not heal. Although various objective tests can supplement the clinical examination, these tests have a wide variability in their sensitivity and should not be used to replace good clinical judgment. (See <a class="local">'Amputation level'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Complications</strong> – Complications following lower extremity amputation are common and include medical complications related to preexisting conditions and local complications related to the surgery, which include stump hematoma, infection, need for repeat amputation, phantom limb syndrome, and flexion contracture. The need for re-amputation at a more proximal level is inversely related to the level of the index amputation, with more proximal amputations less likely to require revision. (See <a class="local">'Complications'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Mortality</strong> – Perioperative mortality rates for major amputation in patients with peripheral artery disease range from 3 to 18 percent and are related to the patient's medical comorbidities (eg, cardiac disease, pulmonary disease). Mortality related directly to the operation is less common. (See <a class="local">'Perioperative mortality'</a> above and <a class="local">'Long-term survival'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Mortality is 11 to 18 percent for above-knee amputation (AKA), 4 to 9 percent for below-knee amputation (BKA), and 2 to 7 percent for foot amputation (total or partial). </p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Mortality rates for amputation performed for nonvascular indications are lower. </p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Patients with diabetes have a 10-fold increased risk for lower extremity amputation compared with those who do not have diabetes, and patients with diabetes are almost twice as likely to require re-amputation as patients without diabetes. Long-term mean survival is also reduced in patients with diabetes. </p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Norgren L, Hiatt WR, Dormandy JA, et al. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). J Vasc Surg 2007; 45 Suppl S:S5.</a></li><li><a class="nounderline abstract_t">Ziegler-Graham K, MacKenzie EJ, Ephraim PL, et al. Estimating the prevalence of limb loss in the United States: 2005 to 2050. Arch Phys Med Rehabil 2008; 89:422.</a></li><li><a class="nounderline abstract_t">Dillingham TR, Pezzin LE, Shore AD. Reamputation, mortality, and health care costs among persons with dysvascular lower-limb amputations. Arch Phys Med Rehabil 2005; 86:480.</a></li><li><a class="nounderline abstract_t">Dillingham TR, Pezzin LE, MacKenzie EJ. Limb amputation and limb deficiency: epidemiology and recent trends in the United States. South Med J 2002; 95:875.</a></li><li><a class="nounderline abstract_t">Heikkinen M, Saarinen J, Suominen VP, et al. Lower limb amputations: differences between the genders and long-term survival. Prosthet Orthot Int 2007; 31:277.</a></li><li><a class="nounderline abstract_t">Parsons CM, Pimiento JM, Cheong D, et al. The role of radical amputations for extremity tumors: a single institution experience and review of the literature. J Surg Oncol 2012; 105:149.</a></li><li><a class="nounderline abstract_t">Fang ZB, Hu FY, Arya S, et al. Preoperative frailty is predictive of complications after major lower extremity amputation. J Vasc Surg 2017; 65:804.</a></li><li><a class="nounderline abstract_t">Aulivola B, Hile CN, Hamdan AD, et al. Major lower extremity amputation: outcome of a modern series. Arch Surg 2004; 139:395.</a></li><li><a class="nounderline abstract_t">Nehler MR, Coll JR, Hiatt WR, et al. Functional outcome in a contemporary series of major lower extremity amputations. J Vasc Surg 2003; 38:7.</a></li><li><a class="nounderline abstract_t">Bhuvaneswar CG, Epstein LA, Stern TA. Reactions to amputation: recognition and treatment. Prim Care Companion J Clin Psychiatry 2007; 9:303.</a></li><li><a class="nounderline abstract_t">Kashani JH, Frank RG, Kashani SR, et al. Depression among amputees. J Clin Psychiatry 1983; 44:256.</a></li><li><a class="nounderline abstract_t">Bratzler DW, Houck PM, Surgical Infection Prevention Guidelines Writers Workgroup, et al. Antimicrobial prophylaxis for surgery: an advisory statement from the National Surgical Infection Prevention Project. Clin Infect Dis 2004; 38:1706.</a></li><li><a class="nounderline abstract_t">Antimicrobial prophylaxis for surgery. Treat Guidel Med Lett 2009; 7:47.</a></li><li><a class="nounderline abstract_t">McIntosh J, Earnshaw JJ. Antibiotic prophylaxis for the prevention of infection after major limb amputation. Eur J Vasc Endovasc Surg 2009; 37:696.</a></li><li><a class="nounderline abstract_t">Sonne-Holm S, Boeckstyns M, Menck H, et al. Prophylactic antibiotics in amputation of the lower extremity for ischemia. A placebo-controlled, randomized trial of cefoxitin. J Bone Joint Surg Am 1985; 67:800.</a></li><li><a class="nounderline abstract_t">Norlin R, Frydén A, Nilsson L, Anséhn S. Short-term cefotaxime prophylaxis reduces the failure rate in lower limb amputations. Acta Orthop Scand 1990; 61:460.</a></li><li><a class="nounderline abstract_t">Huizinga WK, Robbs JV, Bhamjee A, Kritzinger NA. Wound infection after major lower-limb amputation--the role of antibiotic prophylaxis. S Afr J Surg 1986; 24:98.</a></li><li><a class="nounderline abstract_t">Møller BN, Krebs B. Antibiotic prophylaxis in lower limb amputation. Acta Orthop Scand 1985; 56:327.</a></li><li><a class="nounderline abstract_t">Berridge DC, Slack RC, Hopkinson BR, Makin GS. A bacteriological survey of amputation wound sepsis. J Hosp Infect 1989; 13:167.</a></li><li><a class="nounderline abstract_t">Thomsen S, Jakobsen BW, Wethelund JO, et al. Antibiotic prophylaxis in lower-extremity amputations due to ischemia. A prospective, randomized trial of cephalothin versus methicillin. Arch Orthop Trauma Surg 1990; 109:72.</a></li><li><a class="nounderline abstract_t">Friis H. Penicillin G versus cefuroxime for prophylaxis in lower limb amputation. Acta Orthop Scand 1987; 58:666.</a></li><li><a class="nounderline abstract_t">Huizinga WK, Robbs JV, Kritzinger NA. Prevention of wound sepsis in amputations by peri-operative antibiotic cover with an amoxycillin-clavulanic acid combination. S Afr Med J 1983; 63:71.</a></li><li><a class="nounderline abstract_t">Sadat U, Chaudhuri A, Hayes PD, et al. Five day antibiotic prophylaxis for major lower limb amputation reduces wound infection rates and the length of in-hospital stay. Eur J Vasc Endovasc Surg 2008; 35:75.</a></li><li><a class="nounderline abstract_t">Souroullas P, Barnes R, Carradice D, et al. Extended-course antibiotic prophylaxis in lower limb amputation: randomized clinical trial. Br J Surg 2022; 109:426.</a></li><li><a class="nounderline abstract_t">Hall JC, Christiansen KJ, Goodman M, et al. Duration of antimicrobial prophylaxis in vascular surgery. Am J Surg 1998; 175:87.</a></li><li><a class="nounderline abstract_t">Siah CJ, Childs C. A systematic review of the ASEPSIS scoring system used in non-cardiac-related surgery. J Wound Care 2012; 21:124, 126.</a></li><li><a class="nounderline abstract_t">Lastória S, Rollo HA, Yoshida WB, et al. Prophylaxis of deep-vein thrombosis after lower extremity amputation: comparison of low molecular weight heparin with unfractionated heparin. Acta Cir Bras 2006; 21:184.</a></li><li><a class="nounderline abstract_t">Huang ME, Johns JS, White J, Sanford K. Venous thromboembolism in a rehabilitation setting after major lower-extremity amputation. Arch Phys Med Rehabil 2005; 86:73.</a></li><li><a class="nounderline abstract_t">Burke B, Kumar R, Vickers V, et al. Deep vein thrombosis after lower limb amputation. Am J Phys Med Rehabil 2000; 79:145.</a></li><li><a class="nounderline abstract_t">Yeager RA, Moneta GL, Edwards JM, et al. Deep vein thrombosis associated with lower extremity amputation. J Vasc Surg 1995; 22:612.</a></li><li><a class="nounderline abstract_t">Harper DR, Dhall DP, Woodruff PW. Prophylaxis in iliofemoral venous thrombosis. The major amputee as a clinical research model. Br J Surg 1973; 60:831.</a></li><li><a class="nounderline abstract_t">Falck-Ytter Y, Francis CW, Johanson NA, et al. Prevention of VTE in orthopedic surgery patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012; 141:e278S.</a></li><li><a class="nounderline abstract_t">Hill J, Treasure T, Guideline Development Group. Reducing the risk of venous thromboembolism (deep vein thrombosis and pulmonary embolism) in patients admitted to hospital: summary of the NICE guideline. Heart 2010; 96:879.</a></li><li><a class="nounderline abstract_t">Robertson L, Roche A. Primary prophylaxis for venous thromboembolism in people undergoing major amputation of the lower extremity. Cochrane Database Syst Rev 2013; :CD010525.</a></li><li><a class="nounderline abstract_t">Struijk-Mulder MC, van Wijhe W, Sze YK, et al. Death and venous thromboembolism after lower extremity amputation. J Thromb Haemost 2010; 8:2680.</a></li><li><a class="nounderline abstract_t">Vemulapalli S, Greiner MA, Jones WS, et al. Peripheral arterial testing before lower extremity amputation among Medicare beneficiaries, 2000 to 2010. Circ Cardiovasc Qual Outcomes 2014; 7:142.</a></li><li><a class="nounderline abstract_t">Dwars BJ, van den Broek TA, Rauwerda JA, Bakker FC. Criteria for reliable selection of the lowest level of amputation in peripheral vascular disease. J Vasc Surg 1992; 15:536.</a></li><li><a class="nounderline abstract_t">Yamada T, Ohta T, Ishibashi H, et al. Clinical reliability and utility of skin perfusion pressure measurement in ischemic limbs--comparison with other noninvasive diagnostic methods. J Vasc Surg 2008; 47:318.</a></li><li><a class="nounderline abstract_t">Wagner WH, Keagy BA, Kotb MM, et al. Noninvasive determination of healing of major lower extremity amputation: the continued role of clinical judgment. J Vasc Surg 1988; 8:703.</a></li><li><a class="nounderline abstract_t">Hebert JS, Rehani M, Stiegelmar R. Osseointegration for Lower-Limb Amputation: A Systematic Review of Clinical Outcomes. JBJS Rev 2017; 5:e10.</a></li><li><a class="nounderline abstract_t">Srinivasan SS, Tuckute G, Zou J, et al. Agonist-antagonist myoneural interface amputation preserves proprioceptive sensorimotor neurophysiology in lower limbs. Sci Transl Med 2020; 12.</a></li><li><a class="nounderline abstract_t">Vernice NA, Askinas CA, Black GG, et al. Osseointegration for lower-extremity amputees: Operative considerations from the plastic surgeon’s perspective. JBJS Rev 2022; 10:e22.00125.</a></li><li class="breakAll">FDA Approves Prosthetic Implant for Above-the-Knee Amputations, https://www.fda.gov/news-events/press-announcements/fda-approves-prosthetic-implant-above-knee-amputations (Accessed on January 04, 2021).</li><li><a class="nounderline abstract_t">Juhnke DL, Beck JP, Jeyapalina S, Aschoff HH. Fifteen years of experience with Integral-Leg-Prosthesis: Cohort study of artificial limb attachment system. J Rehabil Res Dev 2015; 52:407.</a></li><li><a class="nounderline abstract_t">Al Muderis M, Lu W, Li JJ. Osseointegrated Prosthetic Limb for the treatment of lower limb amputations : Experience and outcomes. Unfallchirurg 2017; 120:306.</a></li><li><a class="nounderline abstract_t">Easterlin MC, Chang DC, Wilson SE. A practical index to predict 30-day mortality after major amputation. Ann Vasc Surg 2013; 27:909.</a></li><li><a class="nounderline abstract_t">Armstrong DG, Lavery LA, Diabetic Foot Study Consortium. Negative pressure wound therapy after partial diabetic foot amputation: a multicentre, randomised controlled trial. Lancet 2005; 366:1704.</a></li><li><a class="nounderline abstract_t">Karanikolas M, Aretha D, Tsolakis I, et al. Optimized perioperative analgesia reduces chronic phantom limb pain intensity, prevalence, and frequency: a prospective, randomized, clinical trial. Anesthesiology 2011; 114:1144.</a></li><li><a class="nounderline abstract_t">Ephraim PL, Wegener ST, MacKenzie EJ, et al. Phantom pain, residual limb pain, and back pain in amputees: results of a national survey. Arch Phys Med Rehabil 2005; 86:1910.</a></li><li><a class="nounderline abstract_t">Huang YJ, Assi PE, Drolet BC, et al. A Systematic Review and Meta-analysis on the Incidence of Patients With Lower-Limb Amputations Who Developed Symptomatic Neuromata in the Residual Limb. Ann Plast Surg 2022; 88:574.</a></li><li><a class="nounderline abstract_t">List EB, Krijgh DD, Martin E, Coert JH. Prevalence of residual limb pain and symptomatic neuromas after lower extremity amputation: a systematic review and meta-analysis. Pain 2021; 162:1906.</a></li><li><a class="nounderline abstract_t">Chung BM, Lee GY, Kim WT, et al. MRI features of symptomatic amputation neuromas. Eur Radiol 2021; 31:7684.</a></li><li><a class="nounderline abstract_t">Berlemont M, Weber R, Willot JP. years of experience with the immediate application of prosthetic devices to amputees of the lower extremities on the operating table. Prosthet Int 1969; 3:8.</a></li><li><a class="nounderline abstract_t">Burgess EM, Romano RL, Zettl CP. Amputation management utilising immediate postsurgical prosthetic fitting. Prosthet Int 1969; 3:28.</a></li><li><a class="nounderline abstract_t">Nawijn SE, van der Linde H, Emmelot CH, Hofstad CJ. Stump management after trans-tibial amputation: a systematic review. Prosthet Orthot Int 2005; 29:13.</a></li><li><a class="nounderline abstract_t">Kane TJ 3rd, Pollak EW. The rigid versus soft postoperative dressing controversy: a controlled study in vascular below-knee amputees. Am Surg 1980; 46:244.</a></li><li><a class="nounderline abstract_t">Slade P, Kochenderfer MJ, Delp SL, Collins SH. Personalizing exoskeleton assistance while walking in the real world. Nature 2022; 610:277.</a></li><li><a class="nounderline abstract_t">Ishmael MK, Archangeli D, Lenzi T. Powered hip exoskeleton improves walking economy in individuals with above-knee amputation. Nat Med 2021; 27:1783.</a></li><li><a class="nounderline abstract_t">Ishmael MK, Tran M, Lenzi T. ExoProsthetics: Assisting Above-Knee Amputees with a Lightweight Powered Hip Exoskeleton. IEEE Int Conf Rehabil Robot 2019; 2019:925.</a></li><li><a class="nounderline abstract_t">Sawicki GS, Beck ON, Kang I, Young AJ. The exoskeleton expansion: improving walking and running economy. J Neuroeng Rehabil 2020; 17:25.</a></li><li><a class="nounderline abstract_t">Belmont PJ Jr, Davey S, Orr JD, et al. Risk factors for 30-day postoperative complications and mortality after below-knee amputation: a study of 2,911 patients from the national surgical quality improvement program. J Am Coll Surg 2011; 213:370.</a></li><li><a class="nounderline abstract_t">Hasanadka R, McLafferty RB, Moore CJ, et al. Predictors of wound complications following major amputation for critical limb ischemia. J Vasc Surg 2011; 54:1374.</a></li><li><a class="nounderline abstract_t">Edwards JB, Wooster MD, Tran T, et al. Factors Associated With Unplanned Reoperation After Above-Knee Amputation. JAMA Surg 2019; 154:461.</a></li><li><a class="nounderline abstract_t">Matielo MF, Presti C, Casella IB, et al. Incidence of ipsilateral postoperative deep venous thrombosis in the amputated lower extremity of patients with peripheral obstructive arterial disease. J Vasc Surg 2008; 48:1514.</a></li><li><a class="nounderline abstract_t">Nowygrod R, Egorova N, Greco G, et al. Trends, complications, and mortality in peripheral vascular surgery. J Vasc Surg 2006; 43:205.</a></li><li><a class="nounderline abstract_t">Fisher DF Jr, Clagett GP, Fry RE, et al. One-stage versus two-stage amputation for wet gangrene of the lower extremity: a randomized study. J Vasc Surg 1988; 8:428.</a></li><li><a class="nounderline abstract_t">Rubin JR, Marmen C, Rhodes RS. Management of failed prosthetic grafts at the time of major lower extremity amputation. J Vasc Surg 1988; 7:673.</a></li><li><a class="nounderline abstract_t">Izumi Y, Satterfield K, Lee S, Harkless LB. Risk of reamputation in diabetic patients stratified by limb and level of amputation: a 10-year observation. Diabetes Care 2006; 29:566.</a></li><li><a class="nounderline abstract_t">Cruz CP, Eidt JF, Capps C, et al. Major lower extremity amputations at a Veterans Affairs hospital. Am J Surg 2003; 186:449.</a></li><li><a class="nounderline abstract_t">Abou-Zamzam AM Jr, Teruya TH, Killeen JD, Ballard JL. Major lower extremity amputation in an academic vascular center. Ann Vasc Surg 2003; 17:86.</a></li><li><a class="nounderline abstract_t">Ploeg AJ, Lardenoye JW, Vrancken Peeters MP, Breslau PJ. Contemporary series of morbidity and mortality after lower limb amputation. Eur J Vasc Endovasc Surg 2005; 29:633.</a></li><li><a class="nounderline abstract_t">Schofield CJ, Libby G, Brennan GM, et al. Mortality and hospitalization in patients after amputation: a comparison between patients with and without diabetes. Diabetes Care 2006; 29:2252.</a></li><li><a class="nounderline abstract_t">Stone PA, Flaherty SK, Hayes JD, AbuRahma AF. Lower extremity amputation: a contemporary series. W V Med J 2007; 103:14.</a></li><li><a class="nounderline abstract_t">Henry AJ, Hevelone ND, Hawkins AT, et al. Factors predicting resource utilization and survival after major amputation. J Vasc Surg 2013; 57:784.</a></li><li><a class="nounderline abstract_t">O'Brien PJ, Cox MW, Shortell CK, Scarborough JE. Risk factors for early failure of surgical amputations: an analysis of 8,878 isolated lower extremity amputation procedures. J Am Coll Surg 2013; 216:836.</a></li><li><a class="nounderline abstract_t">Iannuzzi JC, Chandra A, Rickles AS, et al. Resident involvement is associated with worse outcomes after major lower extremity amputation. J Vasc Surg 2013; 58:827.</a></li><li><a class="nounderline abstract_t">Glaser JD, Bensley RP, Hurks R, et al. Fate of the contralateral limb after lower extremity amputation. J Vasc Surg 2013; 58:1571.</a></li><li><a class="nounderline abstract_t">Blume P, Salonga C, Garbalosa J, et al. Predictors for the healing of transmetatarsal amputations: retrospective study of 91 amputations. Vascular 2007; 15:126.</a></li><li><a class="nounderline abstract_t">Pollard J, Hamilton GA, Rush SM, Ford LA. Mortality and morbidity after transmetatarsal amputation: retrospective review of 101 cases. J Foot Ankle Surg 2006; 45:91.</a></li><li><a class="nounderline abstract_t">Mwipatayi BP, Naidoo NG, Jeffery PC, et al. Transmetatarsal amputation: three-year experience at Groote Schuur Hospital. World J Surg 2005; 29:245.</a></li><li><a class="nounderline abstract_t">Thomas SR, Perkins JM, Magee TR, Galland RB. Transmetatarsal amputation: an 8-year experience. Ann R Coll Surg Engl 2001; 83:164.</a></li><li><a class="nounderline abstract_t">Kono Y, Muder RR. Identifying the incidence of and risk factors for reamputation among patients who underwent foot amputation. Ann Vasc Surg 2012; 26:1120.</a></li><li><a class="nounderline abstract_t">Griffin SC, Tsao JW. A mechanism-based classification of phantom limb pain. Pain 2014; 155:2236.</a></li><li><a class="nounderline abstract_t">Katz J. Phantom limb pain. Lancet 1997; 350:1338.</a></li><li><a class="nounderline abstract_t">Sherman RA, Sherman CJ, Parker L. Chronic phantom and stump pain among American veterans: results of a survey. Pain 1984; 18:83.</a></li><li><a class="nounderline abstract_t">Hanley MA, Jensen MP, Smith DG, et al. Preamputation pain and acute pain predict chronic pain after lower extremity amputation. J Pain 2007; 8:102.</a></li><li><a class="nounderline abstract_t">Nikolajsen L, Ilkjaer S, Christensen JH, et al. Randomised trial of epidural bupivacaine and morphine in prevention of stump and phantom pain in lower-limb amputation. Lancet 1997; 350:1353.</a></li><li><a class="nounderline abstract_t">Gilmore CA, Ilfeld BM, Rosenow JM, et al. Percutaneous 60-day peripheral nerve stimulation implant provides sustained relief of chronic pain following amputation: 12-month follow-up of a randomized, double-blind, placebo-controlled trial. Reg Anesth Pain Med 2019.</a></li><li><a class="nounderline abstract_t">Rutledge T, Velez D, Depp C, et al. A Virtual Reality Intervention for the Treatment of Phantom Limb Pain: Development and Feasibility Results. Pain Med 2019; 20:2051.</a></li><li><a class="nounderline abstract_t">McCormick Z, Chang-Chien G, Marshall B, et al. Phantom limb pain: a systematic neuroanatomical-based review of pharmacologic treatment. Pain Med 2014; 15:292.</a></li><li><a class="nounderline abstract_t">Alviar MJ, Hale T, Dungca M. Pharmacologic interventions for treating phantom limb pain. Cochrane Database Syst Rev 2016; 10:CD006380.</a></li><li><a class="nounderline abstract_t">Richardson C, Kulkarni J. A review of the management of phantom limb pain: challenges and solutions. J Pain Res 2017; 10:1861.</a></li><li><a class="nounderline abstract_t">Osumi M, Inomata K, Inoue Y, et al. Characteristics of Phantom Limb Pain Alleviated with Virtual Reality Rehabilitation. Pain Med 2019; 20:1038.</a></li><li><a class="nounderline abstract_t">Petersen BA, Nanivadekar AC, Chandrasekaran S, Fisher LE. Phantom limb pain: peripheral neuromodulatory and neuroprosthetic approaches to treatment. Muscle Nerve 2019; 59:154.</a></li><li><a class="nounderline abstract_t">Preißler S, Dietrich C, Seifert S, et al. The Feeling Prosthesis-Somatosensory Feedback from the Prosthesis Foot Reduces Phantom Limb Pain Dramatically. Pain Med 2018; 19:1698.</a></li><li><a class="nounderline abstract_t">Dietrich C, Walter-Walsh K, Preissler S, et al. Sensory feedback prosthesis reduces phantom limb pain: proof of a principle. Neurosci Lett 2012; 507:97.</a></li><li><a class="nounderline abstract_t">Dumanian GA, Potter BK, Mioton LM, et al. Targeted Muscle Reinnervation Treats Neuroma and Phantom Pain in Major Limb Amputees: A Randomized Clinical Trial. Ann Surg 2019; 270:238.</a></li><li><a class="nounderline abstract_t">Wasiak K, Paczkowski PM, Garlicki JM. Surgical results of leg amputation according to Ghormley's technique in the treatment of chronic lower limb ischaemia. Acta Chir Belg 2006; 106:52.</a></li><li><a class="nounderline abstract_t">Murdoch DP, Armstrong DG, Dacus JB, et al. The natural history of great toe amputations. J Foot Ankle Surg 1997; 36:204.</a></li><li><a class="nounderline abstract_t">Dalla Paola L, Faglia E, Caminiti M, et al. Ulcer recurrence following first ray amputation in diabetic patients: a cohort prospective study. Diabetes Care 2003; 26:1874.</a></li><li><a class="nounderline abstract_t">Early JS. Transmetatarsal and midfoot amputations. Clin Orthop Relat Res 1999; :85.</a></li><li><a class="nounderline abstract_t">Toursarkissian B, Shireman PK, Harrison A, et al. Major lower-extremity amputation: contemporary experience in a single Veterans Affairs institution. Am Surg 2002; 68:606.</a></li><li><a class="nounderline abstract_t">Schoppen T, Boonstra A, Groothoff JW, et al. Physical, mental, and social predictors of functional outcome in unilateral lower-limb amputees. Arch Phys Med Rehabil 2003; 84:803.</a></li><li><a class="nounderline abstract_t">Taylor SM, Kalbaugh CA, Blackhurst DW, et al. Preoperative clinical factors predict postoperative functional outcomes after major lower limb amputation: an analysis of 553 consecutive patients. J Vasc Surg 2005; 42:227.</a></li><li><a class="nounderline abstract_t">Huston CC, Bivins BA, Ernst CB, Griffen WO Jr. Morbid implications of above-knee amputations. Report of a series and review of the literature. Arch Surg 1980; 115:165.</a></li><li><a class="nounderline abstract_t">Davies B, Datta D. Mobility outcome following unilateral lower limb amputation. Prosthet Orthot Int 2003; 27:186.</a></li><li><a class="nounderline abstract_t">Sauter CN, Pezzin LE, Dillingham TR. Functional outcomes of persons who underwent dysvascular lower extremity amputations: effect of postacute rehabilitation setting. Am J Phys Med Rehabil 2013; 92:287.</a></li><li><a class="nounderline abstract_t">Stern JR, Wong CK, Yerovinkina M, et al. A Meta-analysis of Long-term Mortality and Associated Risk Factors following Lower Extremity Amputation. Ann Vasc Surg 2017; 42:322.</a></li><li><a class="nounderline abstract_t">OTTEMAN MG, STAHLGREN LH. EVALUATION OF FACTORS WHICH INFLUENCE MORTALITY AND MORBIDITY FOLLOWING MAJOR LOWER EXTREMITY AMPUTATIONS FOR ARTERIOSCLEROSIS. Surg Gynecol Obstet 1965; 120:1217.</a></li><li><a class="nounderline abstract_t">Eidemiller LR, Awe WC, Peterson CG. Amputation of the ischemic extremity. Am Surg 1968; 34:491.</a></li><li><a class="nounderline abstract_t">Rosenberg N, Adiarte E, Bujdoso LJ, Backwinkel KD. Mortality factors in major limb amputations for vascular disease: a study of 176 procedures. Surgery 1970; 67:437.</a></li><li><a class="nounderline abstract_t">Sandnes DK, Sobel M, Flum DR. Survival after lower-extremity amputation. J Am Coll Surg 2004; 199:394.</a></li><li><a class="nounderline abstract_t">Feinglass J, Pearce WH, Martin GJ, et al. Postoperative and late survival outcomes after major amputation: findings from the Department of Veterans Affairs National Surgical Quality Improvement Program. Surgery 2001; 130:21.</a></li><li><a class="nounderline abstract_t">Mayfield JA, Reiber GE, Maynard C, et al. Survival following lower-limb amputation in a veteran population. J Rehabil Res Dev 2001; 38:341.</a></li><li><a class="nounderline abstract_t">Kazmers A, Perkins AJ, Jacobs LA. Major lower extremity amputation in Veterans Affairs medical centers. Ann Vasc Surg 2000; 14:216.</a></li><li><a class="nounderline abstract_t">Subramaniam B, Pomposelli F, Talmor D, Park KW. Perioperative and long-term morbidity and mortality after above-knee and below-knee amputations in diabetics and nondiabetics. Anesth Analg 2005; 100:1241.</a></li><li><a class="nounderline abstract_t">Panton AC. VI. A Case of Perforating Typhoid Ulcer, with Recovery, after Operation. Ann Surg 1897; 26:219.</a></li><li><a class="nounderline abstract_t">Nelson MT, Greenblatt DY, Soma G, et al. Preoperative factors predict mortality after major lower-extremity amputation. Surgery 2012; 152:685.</a></li><li><a class="nounderline abstract_t">Jones WS, Patel MR, Dai D, et al. High mortality risks after major lower extremity amputation in Medicare patients with peripheral artery disease. Am Heart J 2013; 165:809.</a></li><li><a class="nounderline abstract_t">Yammine K, Hayek F, Assi C. A meta-analysis of mortality after minor amputation among patients with diabetes and/or peripheral vascular disease. J Vasc Surg 2020; 72:2197.</a></li><li><a class="nounderline abstract_t">Stone PA, Back MR, Armstrong PA, et al. Midfoot amputations expand limb salvage rates for diabetic foot infections. Ann Vasc Surg 2005; 19:805.</a></li><li><a class="nounderline abstract_t">Meshkin DH, Zolper EG, Chang K, et al. Long-term Mortality After Nontraumatic Major Lower Extremity Amputation: A Systematic Review and Meta-analysis. J Foot Ankle Surg 2021; 60:567.</a></li><li><a class="nounderline abstract_t">Shah SK, Bena JF, Allemang MT, et al. Lower extremity amputations: factors associated with mortality or contralateral amputation. Vasc Endovascular Surg 2013; 47:608.</a></li><li><a class="nounderline abstract_t">Wise ES, McMaster WG Jr, Williamson K, et al. Preoperative Predictors of 30-Day Mortality and Prolonged Length of Stay after Above-Knee Amputation. Ann Vasc Surg 2016; 31:124.</a></li><li><a class="nounderline abstract_t">Ebskov B. Relative mortality and long term survival for the non-diabetic lower limb amputee with vascular insufficiency. Prosthet Orthot Int 1999; 23:209.</a></li><li><a class="nounderline abstract_t">Bo Ebskov L. Dysvascular amputations and long-term survival in a 20-year follow-up study. Int J Rehabil Res 2006; 29:325.</a></li><li><a class="nounderline abstract_t">Pohjolainen T, Alaranta H. Ten-year survival of Finnish lower limb amputees. Prosthet Orthot Int 1998; 22:10.</a></li><li><a class="nounderline abstract_t">Feinglass J, Rucker-Whitaker C, Lindquist L, et al. Racial differences in primary and repeat lower extremity amputation: results from a multihospital study. J Vasc Surg 2005; 41:823.</a></li><li><a class="nounderline abstract_t">Fortington LV, Geertzen JH, van Netten JJ, et al. Short and long term mortality rates after a lower limb amputation. Eur J Vasc Endovasc Surg 2013; 46:124.</a></li><li><a class="nounderline abstract_t">Lavery LA, van Houtum WH, Armstrong DG, et al. Mortality following lower extremity amputation in minorities with diabetes mellitus. Diabetes Res Clin Pract 1997; 37:41.</a></li><li><a class="nounderline abstract_t">Collins TC, Johnson M, Daley J, et al. Preoperative risk factors for 30-day mortality after elective surgery for vascular disease in Department of Veterans Affairs hospitals: is race important? J Vasc Surg 2001; 34:634.</a></li></ol></div><div id="topicVersionRevision">Topic 16695 Version 32.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17223489" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18295618" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Estimating the prevalence of limb loss in the United States: 2005 to 2050.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15759232" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Reamputation, mortality, and health care costs among persons with dysvascular lower-limb amputations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12190225" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Limb amputation and limb deficiency: epidemiology and recent trends in the United States.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17979013" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Lower limb amputations: differences between the genders and long-term survival.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21837679" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : The role of radical amputations for extremity tumors: a single institution experience and review of the literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28236922" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Preoperative frailty is predictive of complications after major lower extremity amputation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15078707" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Major lower extremity amputation: outcome of a modern series.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12844082" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Functional outcome in a contemporary series of major lower extremity amputations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17934555" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Reactions to amputation: recognition and treatment.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6863225" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Depression among amputees.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15227616" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Antimicrobial prophylaxis for surgery: an advisory statement from the National Surgical Infection Prevention Project.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19461558" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Antimicrobial prophylaxis for surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19328028" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Antibiotic prophylaxis for the prevention of infection after major limb amputation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3889004" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Prophylactic antibiotics in amputation of the lower extremity for ischemia. A placebo-controlled, randomized trial of cefoxitin.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2239174" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Short-term cefotaxime prophylaxis reduces the failure rate in lower limb amputations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3547697" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Wound infection after major lower-limb amputation--the role of antibiotic prophylaxis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4072649" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Antibiotic prophylaxis in lower limb amputation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2567309" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : A bacteriological survey of amputation wound sepsis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2180390" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Antibiotic prophylaxis in lower-extremity amputations due to ischemia. A prospective, randomized trial of cephalothin versus methicillin.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3327354" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Penicillin G versus cefuroxime for prophylaxis in lower limb amputation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6849168" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Prevention of wound sepsis in amputations by peri-operative antibiotic cover with an amoxycillin-clavulanic acid combination.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17913520" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Five day antibiotic prophylaxis for major lower limb amputation reduces wound infection rates and the length of in-hospital stay.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35325055" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Extended-course antibiotic prophylaxis in lower limb amputation: randomized clinical trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9515521" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Duration of antimicrobial prophylaxis in vascular surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22399080" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : A systematic review of the ASEPSIS scoring system used in non-cardiac-related surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16751933" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Prophylaxis of deep-vein thrombosis after lower extremity amputation: comparison of low molecular weight heparin with unfractionated heparin.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15640993" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Venous thromboembolism in a rehabilitation setting after major lower-extremity amputation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10744188" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Deep vein thrombosis after lower limb amputation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7494364" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Deep vein thrombosis associated with lower extremity amputation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4583966" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Prophylaxis in iliofemoral venous thrombosis. The major amputee as a clinical research model.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22315265" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Prevention of VTE in orthopedic surgery patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20478866" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Reducing the risk of venous thromboembolism (deep vein thrombosis and pulmonary embolism) in patients admitted to hospital: summary of the NICE guideline.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24343728" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Primary prophylaxis for venous thromboembolism in people undergoing major amputation of the lower extremity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21138520" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Death and venous thromboembolism after lower extremity amputation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24425703" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Peripheral arterial testing before lower extremity amputation among Medicare beneficiaries, 2000 to 2010.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1538511" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Criteria for reliable selection of the lowest level of amputation in peripheral vascular disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18241755" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Clinical reliability and utility of skin perfusion pressure measurement in ischemic limbs--comparison with other noninvasive diagnostic methods.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3057247" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Noninvasive determination of healing of major lower extremity amputation: the continued role of clinical judgment.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29087966" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Osseointegration for Lower-Limb Amputation: A Systematic Review of Clinical Outcomes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33298564" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Agonist-antagonist myoneural interface amputation preserves proprioceptive sensorimotor neurophysiology in lower limbs.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Osseointegration for lower-extremity amputees: Operative considerations from the plastic surgeon’s perspective</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Osseointegration for lower-extremity amputees: Operative considerations from the plastic surgeon’s perspective</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26348827" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Fifteen years of experience with Integral-Leg-Prosthesis: Cohort study of artificial limb attachment system.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28070628" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Osseointegrated Prosthetic Limb for the treatment of lower limb amputations : Experience and outcomes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23790769" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : A practical index to predict 30-day mortality after major amputation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16291063" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Negative pressure wound therapy after partial diabetic foot amputation: a multicentre, randomised controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21368651" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Optimized perioperative analgesia reduces chronic phantom limb pain intensity, prevalence, and frequency: a prospective, randomized, clinical trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16213230" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Phantom pain, residual limb pain, and back pain in amputees: results of a national survey.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34270470" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : A Systematic Review and Meta-analysis on the Incidence of Patients With Lower-Limb Amputations Who Developed Symptomatic Neuromata in the Residual Limb.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33470746" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Prevalence of residual limb pain and symptomatic neuromas after lower extremity amputation: a systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33866387" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : MRI features of symptomatic amputation neuromas.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : years of experience with the immediate application of prosthetic devices to amputees of the lower extremities on the operating table</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Amputation management utilising immediate postsurgical prosthetic fitting</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16180374" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Stump management after trans-tibial amputation: a systematic review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7386990" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : The rigid versus soft postoperative dressing controversy: a controlled study in vascular below-knee amputees.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36224415" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Personalizing exoskeleton assistance while walking in the real world.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34635852" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Powered hip exoskeleton improves walking economy in individuals with above-knee amputation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31374748" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : ExoProsthetics: Assisting Above-Knee Amputees with a Lightweight Powered Hip Exoskeleton.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32075669" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : The exoskeleton expansion: improving walking and running economy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21723151" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Risk factors for 30-day postoperative complications and mortality after below-knee amputation: a study of 2,911 patients from the national surgical quality improvement program.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21840153" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Predictors of wound complications following major amputation for critical limb ischemia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30725076" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : Factors Associated With Unplanned Reoperation After Above-Knee Amputation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18829221" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : Incidence of ipsilateral postoperative deep venous thrombosis in the amputated lower extremity of patients with peripheral obstructive arterial disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16476588" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : Trends, complications, and mortality in peripheral vascular surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3172378" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : One-stage versus two-stage amputation for wet gangrene of the lower extremity: a randomized study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3367432" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : Management of failed prosthetic grafts at the time of major lower extremity amputation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16505507" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : Risk of reamputation in diabetic patients stratified by limb and level of amputation: a 10-year observation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14599605" id="rid68" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>69 : Major lower extremity amputations at a Veterans Affairs hospital.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12522704" id="rid69" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>70 : Major lower extremity amputation in an academic vascular center.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15878543" id="rid70" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>71 : Contemporary series of morbidity and mortality after lower limb amputation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17003302" id="rid71" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>72 : Mortality and hospitalization in patients after amputation: a comparison between patients with and without diabetes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18309862" id="rid72" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>73 : Lower extremity amputation: a contemporary series.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23312839" id="rid73" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>74 : Factors predicting resource utilization and survival after major amputation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23521969" id="rid74" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>75 : Risk factors for early failure of surgical amputations: an analysis of 8,878 isolated lower extremity amputation procedures.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23769943" id="rid75" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>76 : Resident involvement is associated with worse outcomes after major lower extremity amputation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23921246" id="rid76" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>77 : Fate of the contralateral limb after lower extremity amputation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17573017" id="rid77" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>78 : Predictors for the healing of transmetatarsal amputations: retrospective study of 91 amputations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16513503" id="rid78" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>79 : Mortality and morbidity after transmetatarsal amputation: retrospective review of 101 cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15645336" id="rid79" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>80 : Transmetatarsal amputation: three-year experience at Groote Schuur Hospital.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11432132" id="rid80" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>81 : Transmetatarsal amputation: an 8-year experience.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22840342" id="rid81" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>82 : Identifying the incidence of and risk factors for reamputation among patients who underwent foot amputation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24857794" id="rid82" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>83 : A mechanism-based classification of phantom limb pain.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9365444" id="rid83" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>84 : Phantom limb pain.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6709380" id="rid84" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>85 : Chronic phantom and stump pain among American veterans: results of a survey.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16949876" id="rid85" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>86 : Preamputation pain and acute pain predict chronic pain after lower extremity amputation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9365449" id="rid86" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>87 : Randomised trial of epidural bupivacaine and morphine in prevention of stump and phantom pain in lower-limb amputation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31740443" id="rid87" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>88 : Percutaneous 60-day peripheral nerve stimulation implant provides sustained relief of chronic pain following amputation: 12-month follow-up of a randomized, double-blind, placebo-controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31165893" id="rid88" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>89 : A Virtual Reality Intervention for the Treatment of Phantom Limb Pain: Development and Feasibility Results.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24224475" id="rid89" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>90 : Phantom limb pain: a systematic neuroanatomical-based review of pharmacologic treatment.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27737513" id="rid90" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>91 : Pharmacologic interventions for treating phantom limb pain.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28860841" id="rid91" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>92 : A review of the management of phantom limb pain: challenges and solutions.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30576543" id="rid92" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>93 : Characteristics of Phantom Limb Pain Alleviated with Virtual Reality Rehabilitation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30152101" id="rid93" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>94 : Phantom limb pain: peripheral neuromodulatory and neuroprosthetic approaches to treatment.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29186620" id="rid94" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>95 : The Feeling Prosthesis-Somatosensory Feedback from the Prosthesis Foot Reduces Phantom Limb Pain Dramatically.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22085692" id="rid95" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>96 : Sensory feedback prosthesis reduces phantom limb pain: proof of a principle.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30371518" id="rid96" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>97 : Targeted Muscle Reinnervation Treats Neuroma and Phantom Pain in Major Limb Amputees: A Randomized Clinical Trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16612914" id="rid97" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>98 : Surgical results of leg amputation according to Ghormley's technique in the treatment of chronic lower limb ischaemia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9232500" id="rid98" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>99 : The natural history of great toe amputations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12766126" id="rid99" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>100 : Ulcer recurrence following first ray amputation in diabetic patients: a cohort prospective study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10212600" id="rid100" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>101 : Transmetatarsal and midfoot amputations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12132742" id="rid101" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>102 : Major lower-extremity amputation: contemporary experience in a single Veterans Affairs institution.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12808530" id="rid102" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>103 : Physical, mental, and social predictors of functional outcome in unilateral lower-limb amputees.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16102618" id="rid103" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>104 : Preoperative clinical factors predict postoperative functional outcomes after major lower limb amputation: an analysis of 553 consecutive patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7356831" id="rid104" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>105 : Morbid implications of above-knee amputations. Report of a series and review of the literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14727699" id="rid105" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>106 : Mobility outcome following unilateral lower limb amputation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23291599" id="rid106" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>107 : Functional outcomes of persons who underwent dysvascular lower extremity amputations: effect of postacute rehabilitation setting.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28389295" id="rid107" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>108 : A Meta-analysis of Long-term Mortality and Associated Risk Factors following Lower Extremity Amputation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14285941" id="rid108" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>109 : EVALUATION OF FACTORS WHICH INFLUENCE MORTALITY AND MORBIDITY FOLLOWING MAJOR LOWER EXTREMITY AMPUTATIONS FOR ARTERIOSCLEROSIS.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/5654531" id="rid109" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>110 : Amputation of the ischemic extremity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/5413439" id="rid110" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>111 : Mortality factors in major limb amputations for vascular disease: a study of 176 procedures.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15325609" id="rid111" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>112 : Survival after lower-extremity amputation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11436008" id="rid112" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>113 : Postoperative and late survival outcomes after major amputation: findings from the Department of Veterans Affairs National Surgical Quality Improvement Program.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11440266" id="rid113" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>114 : Survival following lower-limb amputation in a veteran population.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10796952" id="rid114" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>115 : Major lower extremity amputation in Veterans Affairs medical centers.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15845661" id="rid115" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>116 : Perioperative and long-term morbidity and mortality after above-knee and below-knee amputations in diabetics and nondiabetics.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17860472" id="rid116" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>117 : VI. A Case of Perforating Typhoid Ulcer, with Recovery, after Operation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23021137" id="rid117" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>118 : Preoperative factors predict mortality after major lower-extremity amputation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23622919" id="rid118" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>119 : High mortality risks after major lower extremity amputation in Medicare patients with peripheral artery disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32835790" id="rid119" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>120 : A meta-analysis of mortality after minor amputation among patients with diabetes and/or peripheral vascular disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16205848" id="rid120" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>121 : Midfoot amputations expand limb salvage rates for diabetic foot infections.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33509714" id="rid121" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>122 : Long-term Mortality After Nontraumatic Major Lower Extremity Amputation: A Systematic Review and Meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24005190" id="rid122" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>123 : Lower extremity amputations: factors associated with mortality or contralateral amputation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26616501" id="rid123" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>124 : Preoperative Predictors of 30-Day Mortality and Prolonged Length of Stay after Above-Knee Amputation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10890595" id="rid124" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>125 : Relative mortality and long term survival for the non-diabetic lower limb amputee with vascular insufficiency.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17106350" id="rid125" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>126 : Dysvascular amputations and long-term survival in a 20-year follow-up study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9604271" id="rid126" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>127 : Ten-year survival of Finnish lower limb amputees.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15886667" id="rid127" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>128 : Racial differences in primary and repeat lower extremity amputation: results from a multihospital study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23628328" id="rid128" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>129 : Short and long term mortality rates after a lower limb amputation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9279476" id="rid129" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>130 : Mortality following lower extremity amputation in minorities with diabetes mellitus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11668317" id="rid130" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>131 : Preoperative risk factors for 30-day mortality after elective surgery for vascular disease in Department of Veterans Affairs hospitals: is race important?</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
